Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris.
Douglas WS, Poulin Y, Decroix J, Ortonne JP, Mrowietz U, Gulliver W, Krogstad AL, Larsen FG, Iglesias L, Buckley C, Bibby AJ. Douglas WS, et al. Among authors: bibby aj. Acta Derm Venereol. 2002;82(2):131-5. doi: 10.1080/00015550252948194. Acta Derm Venereol. 2002. PMID: 12125943 Free article. Clinical Trial.
A calcipotriene/betamethasone dipropionate two-compound scalp formulation in the treatment of scalp psoriasis in Hispanic/Latino and Black/African American patients: results of the randomized, 8-week, double-blind phase of a clinical trial.
Tyring S, Mendoza N, Appell M, Bibby A, Foster R, Hamilton T, Lee M. Tyring S, et al. Int J Dermatol. 2010 Nov;49(11):1328-33. doi: 10.1111/j.1365-4632.2010.04598.x. Int J Dermatol. 2010. PMID: 20964660 Clinical Trial.
Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial.
White S, Vender R, Thaçi D, Haverkamp C, Naeyaert JM, Foster R, Martinez Escribano JA, Cambazard F, Bibby A. White S, et al. Am J Clin Dermatol. 2006;7(3):177-84. doi: 10.2165/00128071-200607030-00004. Am J Clin Dermatol. 2006. PMID: 16734505 Clinical Trial.
A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Jolliffe D, Peyri J, Svensson A, Toole J, Wozel G. Kragballe K, et al. Br J Dermatol. 2006 Jun;154(6):1155-60. doi: 10.1111/j.1365-2133.2006.07236.x. Br J Dermatol. 2006. PMID: 16704648 Clinical Trial.
Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris.
Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Williams Z, Peyri Rey J, Svensson A, Toole J, Wozel G. Kragballe K, et al. Dermatology. 2006;213(4):319-26. doi: 10.1159/000096069. Dermatology. 2006. PMID: 17135738 Clinical Trial.